Literature DB >> 35915319

An Enthalpy-Balance Model for Timewise Evolution of Temperature during Wet Stirred Media Milling of Drug Suspensions.

Gulenay Guner1, Sherif Elashri1, Mirsad Mehaj1, Natasha Seetharaman1, Helen F Yao2, Donald J Clancy2, Ecevit Bilgili3.   

Abstract

PURPOSE: Nanosuspensions have been used for enhancing the bioavailability of poorly soluble drugs. This study explores the temperature evolution during their preparation in a wet stirred media mill using a coupled experimental-enthalpy balance approach.
METHODS: Milling was performed at three levels of stirrer speed, bead loading, and bead sizes. Temperatures were recorded over time, then simulated using an enthalpy balance model by fitting the fraction of power converted to heat ξ. Moreover, initial and final power, ξ, and temperature profiles at 5 different test runs were predicted by power-law (PL) and machine learning (ML) approaches.
RESULTS: Heat generation was higher at the higher stirrer speed and bead loading/size, which was explained by the higher power consumption. Despite its simplicity with a single fitting parameter ξ, the enthalpy balance model fitted the temperature evolution well with root mean squared error (RMSE) of 0.40-2.34°C. PL and ML approaches provided decent predictions of the temperature profiles in the test runs, with RMSE of 0.93-4.17 and 1.00-2.17°C, respectively.
CONCLUSIONS: We established the impact of milling parameters on heat generation-power and demonstrated the simulation-prediction capability of an enthalpy balance model when coupled to the PL-ML approaches.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  enthalpy balance; heat dissipation; poorly water-soluble drugs; process modeling; wet stirred media milling

Mesh:

Substances:

Year:  2022        PMID: 35915319     DOI: 10.1007/s11095-022-03346-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  26 in total

1.  Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization.

Authors:  V Jenning; A Lippacher; S H Gohla
Journal:  J Microencapsul       Date:  2002 Jan-Feb       Impact factor: 3.142

2.  Optimization of formulation and process variable of nanosuspension: An industrial perspective.

Authors:  Dhananjay S Singare; Seshasai Marella; K Gowthamrajan; Giriraj T Kulkarni; Rajesh Vooturi; Parchuri Srinivasa Rao
Journal:  Int J Pharm       Date:  2010-10-07       Impact factor: 5.875

Review 3.  Nanosizing--oral formulation development and biopharmaceutical evaluation.

Authors:  Filippos Kesisoglou; Santipharp Panmai; Yunhui Wu
Journal:  Adv Drug Deliv Rev       Date:  2007-05-25       Impact factor: 15.470

4.  Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.

Authors:  Sachin Kumar Singh; K K Srinivasan; K Gowthamarajan; Dhananjay S Singare; Dev Prakash; Narayan Babulal Gaikwad
Journal:  Eur J Pharm Biopharm       Date:  2011-03-23       Impact factor: 5.571

5.  Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.

Authors:  Bhupesh K Ahuja; Sunil K Jena; Sharan K Paidi; Surbhi Bagri; Sarasija Suresh
Journal:  Int J Pharm       Date:  2014-12-06       Impact factor: 5.875

Review 6.  Strategies to address low drug solubility in discovery and development.

Authors:  Hywel D Williams; Natalie L Trevaskis; Susan A Charman; Ravi M Shanker; William N Charman; Colin W Pouton; Christopher J H Porter
Journal:  Pharmacol Rev       Date:  2013-01       Impact factor: 25.468

Review 7.  Computational prediction of formulation strategies for beyond-rule-of-5 compounds.

Authors:  Christel A S Bergström; William N Charman; Christopher J H Porter
Journal:  Adv Drug Deliv Rev       Date:  2016-02-27       Impact factor: 15.470

8.  Scale-up from batch to flow-through wet milling process for injectable depot formulation.

Authors:  Róbert Lehocký; Daniel Pěček; František Štěpánek
Journal:  Eur J Pharm Sci       Date:  2016-08-26       Impact factor: 4.384

9.  A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.

Authors:  Pooja J Patel; Bhavin Y Gajera; Rutesh H Dave
Journal:  Drug Dev Ind Pharm       Date:  2018-10-12       Impact factor: 3.225

10.  Sustained-release progesterone nanosuspension following intramuscular injection in ovariectomized rats.

Authors:  Heba F Salem
Journal:  Int J Nanomedicine       Date:  2010-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.